Saposin c-dops: a novel anti-tumor agent

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2522833

Compositions and methods for treating subjects with disorders characterized by hyper-proliferating cells such as tumors and cancers are provided. The compositions comprise agents that are combinations of saposin C ( or prosaposin-related polypeptides and dioleoylphosphatidylserine ( or inner leaflet components ). This anti-tumor agent is administered in the methods of the invention according to a dosing regimen. Administering an agent of the invention results in a positive therapeutic response in a subject with a tumor.

L'invention concerne des compositions et des méthodes permettant de traiter des sujets souffrant de troubles caractérisés par une hyperprolifération de cellules, comme dans le cas de tumeurs et de cancers. Les compositions comprennent des agents qui sont des combinaisons de saposine C (ou de polypeptides apparentés à la prosaposine) et de dioléoylphosphatidylsérine (ou de constituants de lamelle intérieure). Cet agent antitumoral est administré dans le cadre de méthodes de l'invention, selon un schéma posologique. L'administration d'un agent de l'invention induit une réponse thérapeutique positive chez un sujet atteint d'une tumeur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Saposin c-dops: a novel anti-tumor agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Saposin c-dops: a novel anti-tumor agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saposin c-dops: a novel anti-tumor agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1395832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.